133 related articles for article (PubMed ID: 24271521)
1. Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats.
Teunissen MW; Brorens IO; De Langen HJ; Geerlings AM; Breimer DD
Pharm Res; 1986 Jun; 3(3):156-61. PubMed ID: 24271521
[TBL] [Abstract][Full Text] [Related]
2. Correlation between antipyrine metabolite formation and theophylline metabolism in humans after simultaneous single-dose administration and at steady state.
Teunissen MW; De Leede LG; Boeijinga JK; Breimer DD
J Pharmacol Exp Ther; 1985 Jun; 233(3):770-5. PubMed ID: 4009489
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.
van der Graaff M; Vermeulen NP; Joeres RP; Vlietstra T; Breimer DD
J Pharmacol Exp Ther; 1983 Nov; 227(2):459-65. PubMed ID: 6631725
[TBL] [Abstract][Full Text] [Related]
4. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo.
Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137
[TBL] [Abstract][Full Text] [Related]
5. The influence of dietary restriction on the metabolism of theophylline and antipyrine in the ageing female BN/BiRij rat.
Groen K; Breimer DD; Brouwer A; Schijff G; Jansen EJ; van Bezooijen CF
J Pharmacol Exp Ther; 1995 Jul; 274(1):143-7. PubMed ID: 7616391
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of simultaneously administered antipyrine and theophylline in male BN/BiRij rats before and after induction with 3-methylcholanthrene.
Groen K; Breimer DD; van Bezooijen CF
Drug Metab Dispos; 1992; 20(4):502-6. PubMed ID: 1356725
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach.
Schellens JH; van der Wart JH; Danhof M; van der Velde EA; Breimer DD
Br J Clin Pharmacol; 1988 Oct; 26(4):373-84. PubMed ID: 3190987
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
St Peter JV; Abul-Hajj Y; Awni WM
Pharm Res; 1991 Dec; 8(12):1470-6. PubMed ID: 1808608
[TBL] [Abstract][Full Text] [Related]
9. Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach.
Schellens JH; Janssens AR; van der Wart JH; van der Velde EA; Breimer DD
Eur J Clin Invest; 1989 Oct; 19(5):472-9. PubMed ID: 2511024
[TBL] [Abstract][Full Text] [Related]
10. Metabolism of antipyrine and m-xylene in rats after prolonged pretreatment with xylene alone or xylene with ethanol, phenobarbital or 3-methylcholanthrene.
Elovaara E; Engström K; Häyri L; Hase T; Aitio A
Xenobiotica; 1989 Sep; 19(9):945-60. PubMed ID: 2815836
[TBL] [Abstract][Full Text] [Related]
11. The effect of age on the oxidative metabolism of antipyrine by uninduced microsomal fractions of rat liver.
Van Geel CA; Van Bezooijen CF
Mech Ageing Dev; 1990 Apr; 53(2):169-77. PubMed ID: 2342384
[TBL] [Abstract][Full Text] [Related]
12. The effect of sex on antipyrine metabolism in cattle at different ages.
Janus K; Antoszek J
J Vet Pharmacol Ther; 1999 Jun; 22(3):163-9. PubMed ID: 10447826
[TBL] [Abstract][Full Text] [Related]
13. Antipyrine metabolite formation and excretion in patients with chronic renal failure.
Teunissen MW; Kampf D; Roots I; Vermeulen NP; Breimer DD
Eur J Clin Pharmacol; 1985; 28(5):589-95. PubMed ID: 4043202
[TBL] [Abstract][Full Text] [Related]
14. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats.
Teunissen MW; Van Graft M; Vermeulen NP; Breimer DD
Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682
[TBL] [Abstract][Full Text] [Related]
15. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
[TBL] [Abstract][Full Text] [Related]
16. Effect of fusidic acid on the hepatic cytochrome P450 enzyme system.
Reimann G; Barthel B; Rockstroh JK; Spatz D; Brockmeyer NH
Int J Clin Pharmacol Ther; 1999 Nov; 37(11):562-6. PubMed ID: 10584978
[TBL] [Abstract][Full Text] [Related]
17. The influence of aging on the metabolism of simultaneously administered hexobarbital enantiomers and antipyrine before and after phenobarbital induction in male rats: a longitudinal study.
Groen K; Breimer DD; Jansen EJ; van Bezooijen CF
J Pharmacol Exp Ther; 1994 Feb; 268(2):531-6. PubMed ID: 8113964
[TBL] [Abstract][Full Text] [Related]
18. Studies on the different metabolic pathways of antipyrine in rats: influence of phenobarbital and 3-methylcholanthrene treatment.
Danhof M; Krom DP; Breimer DD
Xenobiotica; 1979 Nov; 9(11):695-702. PubMed ID: 119355
[TBL] [Abstract][Full Text] [Related]
19. Effect of tacrine hydrochloride on hepatic drug metabolism.
Danbury TC; Eccles M; Ford J; Roberts CJ
Eur J Drug Metab Pharmacokinet; 1999; 24(1):91-6. PubMed ID: 10412897
[TBL] [Abstract][Full Text] [Related]
20. Substrate-selective inhibition by verapamil and diltiazem: differential disposition of antipyrine and theophylline in humans.
Abernethy DR; Egan JM; Dickinson TH; Carrum G
J Pharmacol Exp Ther; 1988 Mar; 244(3):994-9. PubMed ID: 3252045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
